Medical Developments International Limited
(ASX:MVP) has announced it has finalised a distribution deal with McKesson Corporation for its Space Chamber respiratory devices.
McKesson are the largest healthcare supply chain in Northern America and is ranked in the top 20 Forbes 500 companies in the US.
As part of the deal, McKesson has already placed its first order for stock, which is scheduled for delivery in December.
Medical Developments Chairman David Williams has also indicated the company expects business as usual under the incoming Trump administration, noting he expects the new Congress to focus less on drug pricing, which he says is a good outcome for biotech companies.
Medical Developments International Limited reported a net profit of $1.57 million at 30 June 2016.
